Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by JonEcashon Apr 18, 2012 7:51pm

125 Views

Post# 19810215

RE: Next news

Welcome fivenine. Not sure when it was filed either, but per that Ahead of the Herd article:

Philip: Yes, Health Canada is currently in the process of reviewing the documents to allow the start of the clinical trial. In addition, we have manufactured the Cell Pouch™ according to ISO13485 standards, which means our device has been made according to the strictest guidelines and meets regulatory standards for Canada, the U.S. and Europe.

The anticipation is that we are going to be starting our clinical trial in early Q2’12, pending Health Canada clearance.

Early Q2 would mean sometime within the next 2-3 weeks from now.

Bullboard Posts

Canadian government approves Glencore’s takeover of Teck’s coal business